We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+25.53%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.84B
AUM Growth
+$360M
Cap. Flow
-$149M
Cap. Flow %
-5.26%
Top 10 Hldgs %
25.12%
Holding
310
New
37
Increased
50
Reduced
189
Closed
10

Top Buys

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$24.7M
2
ARNA
Arena Pharmaceuticals Inc
ARNA
+$21.7M
3
FOLD
Amicus Therapeutics
FOLD
+$12.1M
4
PBH icon
Prestige Consumer Healthcare
PBH
+$11.6M
5
LGND icon
Ligand Pharmaceuticals
LGND
+$10.8M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$51M
2
ETSY icon
Etsy
ETSY
+$38.3M
3
AIMT
Aimmune Therapeutics
AIMT
+$33.6M
4
BSTC
BioSpecifics Technologies Corp.
BSTC
+$19.5M
5
TTD icon
Trade Desk
TTD
+$12.2M

Sector Composition

Rank Sector Weight
1 Healthcare 26.47%
2 Technology 23.43%
3 Industrials 17.34%
4 Consumer Discretionary 13.01%
5 Communication Services 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WPX
226
DELISTED
WPX Energy, Inc.
WPX
$1.47M 0.05%
179,705
-52,825
-23% -$336K
CYRX icon
227
CryoPort
CYRX
$751M
$1.45M 0.05%
33,015
-1,340
-4% -$63.8K
RYTM icon
228
Rhythm Pharmaceuticals
RYTM
$7.95B
$1.45M 0.05%
48,723
-5,868
-11% -$149K
DSPG
229
DELISTED
DSP Group Inc
DSPG
$1.42M 0.05%
85,700
-3,461
-4% -$53.3K
QDEL icon
230
QuidelOrtho
QDEL
$943M
$1.39M 0.05%
+7,748
New +$1.72M
KEX icon
231
Kirby Corp
KEX
$7B
$1.36M 0.05%
26,342
-6,812
-21% -$310K
LNTH icon
232
Lantheus
LNTH
$6.59B
$1.33M 0.05%
98,773
-4,070
-4% -$53.3K
NATI
233
DELISTED
National Instruments Corp
NATI
$1.27M 0.04%
28,911
-2,786
-9% -$104K
DENN
234
DELISTED
Denny's
DENN
$1.26M 0.04%
86,063
+5,812
+7% +$66.5K
GNTY
235
DELISTED
Guaranty Bancshares
GNTY
$1.26M 0.04%
46,328
-2,161
-4% -$57.3K
ARAY icon
236
Accuray
ARAY
$34.9M
$1.25M 0.04%
+300,814
New +$1.1M
HRMY icon
237
Harmony Biosciences
HRMY
$2.27B
$1.24M 0.04%
+34,275
New +$1.38M
BRK.B icon
238
Berkshire Hathaway Class B
BRK.B
$1.13T
$1.18M 0.04%
5,084
-1,975
-28% -$435K
MIXT
239
DELISTED
MIX TELEMATICS LIMITED
MIXT
$1.15M 0.04%
91,183
+6,125
+7% +$60.3K
CHNG
240
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$1.14M 0.04%
61,147
+48,800
+395% +$802K
GRA
241
DELISTED
W.R. Grace & Co.
GRA
$1.08M 0.04%
19,736
-13,426
-40% -$676K
HAS icon
242
Hasbro
HAS
$13.3B
$1.08M 0.04%
11,502
-3,661
-24% -$325K
BDSI
243
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1.07M 0.04%
+255,386
New +$984K
AAPL icon
244
Apple
AAPL
$4.5T
$1M 0.04%
7,568
-200
-3% -$24.1K
CODA icon
245
Coda Octopus Group
CODA
$117M
$995K 0.04%
158,238
+6,111
+4% +$35.9K
ABT icon
246
Abbott
ABT
$188B
$890K 0.03%
8,126
-50
-0.6% -$5.43K
ABBV icon
247
AbbVie
ABBV
$438B
$842K 0.03%
7,854
-490
-6% -$47.1K
DBI icon
248
Designer Brands
DBI
$334M
$806K 0.03%
+105,309
New +$701K
SRDX
249
DELISTED
Surmodics
SRDX
$790K 0.03%
+18,144
New +$714K
ABCB icon
250
Ameris Bancorp
ABCB
$5.88B
$778K 0.03%
20,425
– –
8 9
10
11 12

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM

Rice Hall James & Associates's Q4 2020 Portfolio in Review

As of Q4 2020, Rice Hall James & Associates held 310 positions worth $2.84B, up 15% from $2.48B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $149M in Q4 2020, closing 10 positions and reducing 189 holdings. Its most notable exit was Immunomedics Inc, an estimated $51M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in Medpace worth $27.3M.

  • Rice Hall James & Associates's largest Q4 2020 buy was Medpace: 195,984 shares worth $27.3M.
  • Rice Hall James & Associates added most to Prestige Consumer Healthcare in Q4 2020, an estimated $11.6M increase.
  • Rice Hall James & Associates's biggest Q4 2020 reduction was Etsy, cutting an estimated $38.3M.
  • Rice Hall James & Associates fully exited Immunomedics Inc in Q4 2020, selling an estimated $51M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $2.84B portfolio in Q4 2020.
  • Rice Hall James & Associates opened 37 new positions and closed 10 in Q4 2020.
  • Rice Hall James & Associates's portfolio value rose 15% quarter-over-quarter to $2.84B.

Based on Rice Hall James & Associates's 13F filing for Q4 2020, filed 16 Feb 2021.